Northwell Health’s Feinstein Institutes in Manhasset will receive a $10 million grant as part of the state’s Long Island Investment Fund, which will finance new state-of-the-art labs to support general medical research on studying infectious diseases, officials announced.
The funds Feinstein will receive are part of the $350 million statewide grant to finance large-scale projects that will have a lasting impact throughout Long Island ranging from supporting downtown revitalization to various innovation endeavors, officials announced. Gov. Kathy Hochul touted the importance to fund cutting-edge, life-saving research throughout the state that institutes such as Feinstein conduct.
“Our investment in the Institute of Bioelectronic Medicine is already improving the lives of everyday New Yorkers, and the additional Long Island Investment Fund award announced today reaffirms our commitment to remaining a national leader in the health and medical research fields,” Hochul said in a statement. “I am proud to support the Feinstein Institutes and their research, which will lead to life-changing medicine and treatments that will improve the lives of New Yorkers on Long Island and across the state.”
Additionally, Feinstein recently completed a $35 million 20,000 square-foot renovation project to energize future breakthroughs in the bioelectronic field with $30 million coming from New York’s Empire State Development.
The renovated lab includes 13 private offices, cold storage rooms,100 research and administrative workstations, conference rooms and more than 1,300 square feet of wet-lab bench space, according to officials.
“At Northwell, we strive to improve the health of the communities we serve and are committed to providing the highest quality clinical care, educating the current and future generations of healthcare professionals, and searching for new advances in medicine at the Feinstein Institutes for Medical Research,” Northwell Health President and CEO Michael Dowling said in a statement.
The lab renovation included the creation of a new biosafety facility, which allows for new research into infectious diseases and complex viruses, in response to the coronavirus pandemic.
As a result of the expansion and state grants, Feinstein will be able to hire 13 new principal investigators and support 100 new staff hires.
“Day in and day out our scientists and staff work tirelessly to research and develop novel therapies for cancer, diabetes, obesity, lupus, among others, and we continue to lead in bioelectronic medicine research,” Feinstein Institutes President and CEO Kevin J. Tracey said in a statement. “We can now hire additional investigators, expand our research capabilities and solidify Nassau County and the Feinstein Institutes as the destination for scientific discoveries.”